SANDRA HIPPLE: Open Payments
NPI 1982909016 · LEXINGTON, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,105 in 68 payments from 17 companies in 2025. Trend: 2023 $767 · 2024 $855 · 2025 $1,105
Food & beverage: $1,105
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $165 |
| Alkermes, Inc. | 10 | $158 |
| Axsome Therapeutics, Inc. | 9 | $138 |
| Neurocrine BioSciences, Inc. | 6 | $109 |
| Lundbeck LLC | 5 | $87 |
| Otsuka America Pharmaceutical, Inc. | 4 | $79 |
| Vanda Pharmaceuticals Inc. | 5 | $78 |
| E.R. Squibb & Sons, L.L.C. | 4 | $67 |
| Teva Pharmaceuticals USA, Inc. | 3 | $58 |
| Collegium Pharmaceutical, Inc. | 2 | $35 |
Products named: VRAYLAR, Auvelity, REXULTI, ARISTADA, INGREZZA, COBENFY, FANAPT, AUSTEDO XR.
Industry payments across NC — which companies pay providers there.
